Raltitrexed, S-1 and fruquintinib (RSF) in the treatment of refractory metastatic colorectal cancer: study protocol for a multicenter, prospective, single-arm, phase II trial

Authors

Institutions

Publication Details

Journal
BMC Cancer
Published
2025-02-28
DOI
https://doi.org/10.1186/s12885-025-13654-7
Primary Topic
Colorectal Cancer Treatments and Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Raltitrexed, S-1 and fruquintinib (RSF) in the treatment of refractory metastatic colorectal cancer: study protocol for a multicenter, prospective, single-arm, phase II trial

Meng Qiu, Peng Cao, Zhenpeng Wen, Han Wang et al.
BMC Cancer
Colorectal Cancer Treatments and Studies
article

Raltitrexed, S-1 and fruquintinib (RSF) in the treatment of refractory metastatic colorectal cancer: study protocol for a multicenter, prospective, single-arm, phase II trial

Meng Qiu, Peng Cao, Zhenpeng Wen, Han Wang, Jiyan Liu, Weibing Leng, Deyun Luo
article en

Abstract

No abstract available for this paper.
BMC CancerVol. 25(1)
Sichuan University (CN), West China Hospital of Sichuan University (CN)
Beijing Xisike Clinical Oncology Research Foundation
Good health and well-being
Openalex Percentile: Top 95%
Colorectal Cancer Treatments and Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.